GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (STU:18C) » Definitions » Float Percentage Of Total Shares Outstanding

GB Sciences (STU:18C) Float Percentage Of Total Shares Outstanding : 99.62% (As of Jun. 13, 2024)


View and export this data going back to 2016. Start your Free Trial

What is GB Sciences Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GB Sciences's float shares is 404.53 Mil. GB Sciences's total shares outstanding is 406.07 Mil. GB Sciences's float percentage of total shares outstanding is 99.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GB Sciences's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GB Sciences's Institutional Ownership is 0.01%.


GB Sciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

GB Sciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=404.53/406.07
=99.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GB Sciences (STU:18C) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (STU:18C) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
9205 W. Russell Road, Suite 240, Las vegas, NV, USA, 89148
GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.

GB Sciences (STU:18C) Headlines

No Headlines